GenapSys Revenue and Competitors

Location

$319M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • GenapSys's estimated annual revenue is currently $17.1M per year.(i)
  • GenapSys's estimated revenue per employee is $155,000
  • GenapSys's total funding is $319M.

Employee Data

  • GenapSys has 110 Employees.(i)
  • GenapSys grew their employee count by -29% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$4280M11139-4%$28M$63.3B
Add Company

What Is GenapSys?

At GenapSys we are working to power the world of healthcare and diagnostics with advanced DNA sequencing technology. Our sequencing instrument platform leverages a proprietary electrical microfluidic sequencing chip with a scalable number of detectors, enabling a wide range of applications including targeted sequencing in oncology, pharmacogenomics and genome-wide sequencing in microbiology and others. We believe in a world where every researcher has a compact, scalable, and affordable sequencer in their own lab, empowering the democratization of genetic sequencing. Our novel sequencing method is revolutionizing genomics discovery, biomedical research, healthcare, diagnostics, agriculture, and a variety of other fields. Our team brings together an incredibly diverse and multidisciplinary set of backgrounds and skills ᅢᄁ¬ツᆲ¬タワ from electrical and mechanical engineers, physicists, chemists, microfluidic engineers, molecular biologists, bioinformaticians, mathematicians and more. It is a super exciting time to join GenapSys as we recently launched our first product which is generating a tremendous amount of interest.

keywords:saas

$319M

Total Funding

110

Number of Employees

$17.1M

Revenue (est)

-29%

Employee Growth %

N/A

Valuation

N/A

Accelerator

GenapSys News

2022-04-17 - Biotech leaders seek to make Boulder into a top city for industry

“I'm thankful to BioFontiers,” said Genapsys Inc. CEO Jason Myers, crediting the institute with helping nurture his former business ArcherDX...

2021-07-08 - GenapSys Expands Executive and Leadership Teams with Key New Hires

REDWOOD CITY, Calif., July 8, 2021 /PRNewswire/ -- GenapSys, Inc. (GenapSys), a company developing a highly accurate and scalable electronic sequencing platform, today announced the addition of Dana Moss to the Company's executive team, and further expanded the Company's leadership team with t ...

2021-06-24 - GenapSys™ Announces Additions to the Company's Executive Team

REDWOOD CITY, Calif., June 24, 2021 /PRNewswire/ -- GenapSys, Inc. (GenapSys), a company developing a highly accurate and scalable electronic sequencing platform, today announced the additions of Britton Russell, Mary Stewart, and Surekha Karudapuram to its executive team. "We are pleased to ...

2021-05-27 - Electronic Sequencing Platform GenapSys Raises $70 Million

GenapSys, a company developing a highly accurate and scalable electronic sequencing platform, announced it has raised $70 million in a Series D round. GenapSys — a company developing a highly accurate and scalable electronic sequencing platform — announced it has raised $70 million in a Series ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$17.2M111-7%N/A
#2
$17.2M11125%$187.4M
#3
$19.4M1146%N/A
#4
$30.8M114-7%N/A
#5
$15M1175%N/A